Suoping Zhai
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Cancer-related Molecular Pathways
- Drug Transport and Resistance Mechanisms
Papers in
-
- Genomics, phytochemicals, and oxidative stress 2
- Oncology 6
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
- Co-authors
- William D. Figg (12 shared papers)Robert E. Vestal (6 shared papers)Edward A. Sausville (6 shared papers)Fred K. Friedman (4 shared papers)Renke Dai (4 shared papers)Adrian M. Senderowicz (4 shared papers)Xiaoxiong Wei (5 shared papers)Seth M. Steinberg (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)The Journal of Clinical Pharmacology (3 papers)Clinical Cancer Research (2 papers)Annals of Pharmacotherapy (2 papers)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- United StatesIndiaItaly
In The Last Decade
Suoping Zhai
25 papers receiving 935 citations
Peers
Comparison fields: 5 of 82
- Pharmacology 112
- Oncology 283
- Otorhinolaryngology 33
- Hematology 65
- Molecular Biology 392
Countries citing papers authored by Suoping Zhai
This map shows the geographic impact of Suoping Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suoping Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suoping Zhai more than expected).
Fields of papers citing papers by Suoping Zhai
This network shows the impact of papers produced by Suoping Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suoping Zhai. The network helps show where Suoping Zhai may publish in the future.
Co-authors
The 25 scholars most cited alongside Suoping Zhai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. | 2002 | 117 |
| 2 | 2002 | 103 | |
| 3 | Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. | 1998 | 102 |
| 4 | 2002 | 94 | |
| 5 | 2003 | 75 | |
| 6 | 2005 | 56 | |
| 7 | 2004 | 55 | |
| 8 | 2004 | 53 | |
| 9 | 2001 | 51 | |
| 10 | 2001 | 42 | |
| 11 | 2015 | 28 | |
| 12 | 1998 | 26 | |
| 13 | 2002 | 25 | |
| 14 | 1995 | 24 | |
| 15 | 2003 | 20 | |
| 16 | 1998 | 19 | |
| 17 | 1999 | 15 | |
| 18 | 2004 | 12 | |
| 19 | 1996 | 11 | |
| 20 | 1994 | 10 |
About Suoping Zhai
Suoping Zhai is a scholar working on Molecular Biology, Oncology, Surgery, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 967 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Diabetes Management and Research (3 papers), Pancreatic function and diabetes (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Cancer Treatment and Pharmacology (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Pharmacology (112 citations), Oncology (283 citations), Otorhinolaryngology (33 citations), Hematology (65 citations) and Molecular Biology (392 citations). Suoping Zhai has collaborated with scholars based in United States, India and Italy. Frequent co-authors include William D. Figg, Robert E. Vestal, Edward A. Sausville, Fred K. Friedman, Renke Dai, Adrian M. Senderowicz, Xiaoxiong Wei, Seth M. Steinberg, Jianguo Zhi and Sandra M. Swain. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Pharmacology, Clinical Cancer Research, Annals of Pharmacotherapy and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.